Free Trial
NASDAQ:THAR

Tharimmune (THAR) Stock Price, News & Analysis

Tharimmune logo
$1.66 +0.04 (+2.47%)
Closing price 07/23/2025 04:00 PM Eastern
Extended Trading
$1.97 +0.31 (+18.67%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tharimmune Stock (NASDAQ:THAR)

Key Stats

Today's Range
$1.61
$1.66
50-Day Range
$1.29
$1.94
52-Week Range
$0.95
$6.39
Volume
19,303 shs
Average Volume
370,527 shs
Market Capitalization
$4.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Strong Buy

Company Overview

Tharimmune Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

THAR MarketRank™: 

Tharimmune scored higher than 50% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tharimmune has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tharimmune has received no research coverage in the past 90 days.

  • Read more about Tharimmune's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tharimmune is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tharimmune is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tharimmune has a P/B Ratio of 2.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Tharimmune's valuation and earnings.
  • Percentage of Shares Shorted

    2.15% of the float of Tharimmune has been sold short.
  • Short Interest Ratio / Days to Cover

    Tharimmune has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tharimmune has recently increased by 107.14%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Tharimmune does not currently pay a dividend.

  • Dividend Growth

    Tharimmune does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.15% of the float of Tharimmune has been sold short.
  • Short Interest Ratio / Days to Cover

    Tharimmune has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tharimmune has recently increased by 107.14%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    2 people have searched for THAR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Tharimmune to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tharimmune insiders have bought more of their company's stock than they have sold. Specifically, they have bought $592,464.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    10.01% of the stock of Tharimmune is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 1.16% of the stock of Tharimmune is held by institutions.

  • Read more about Tharimmune's insider trading history.
Receive THAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter.

THAR Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Tharimmune CFO Don Kim Resigns
See More Headlines

THAR Stock Analysis - Frequently Asked Questions

Tharimmune's stock was trading at $2.03 at the start of the year. Since then, THAR shares have decreased by 18.2% and is now trading at $1.66.

Tharimmune, Inc. (NASDAQ:THAR) posted its earnings results on Monday, May, 12th. The company reported ($0.99) EPS for the quarter, missing the consensus estimate of ($0.84) by $0.15.

Shares of Tharimmune reverse split on the morning of Tuesday, May 28th 2024.The 1-15 reverse split was announced on Tuesday, May 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of THAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tharimmune investors own include Jiuzi (JZXN), Avenue Therapeutics (ATXI), Scinai Immunotherapeutics (SCNI), Adial Pharmaceuticals (ADIL), Sphere 3D (ANY), Blackboxstocks (BLBX).

Company Calendar

Last Earnings
5/12/2025
Today
7/24/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:THAR
Previous Symbol
NASDAQ:THAR
CIK
1861657
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$17.00
Potential Upside/Downside
+924.1%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($7.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-489.33%
Return on Assets
-264.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.67
Quick Ratio
0.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.68 per share
Price / Book
2.44

Miscellaneous

Outstanding Shares
2,660,000
Free Float
2,395,000
Market Cap
$4.42 million
Optionable
Not Optionable
Beta
1.21
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:THAR) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners